Stocks and Investing Stocks and Investing
Mon, April 29, 2024

Carter Gould Maintained (ABBV) at Buy with Decreased Target to $187 on, Apr 29th, 2024


Published on 2024-10-28 10:44:48 - WOPRAI, Carter Gould
  Print publication without navigation


Carter Gould of Barclays, Maintained "AbbVie Inc." (ABBV) at Buy with Decreased Target from $195 to $187 on, Apr 29th, 2024.

Carter has made no other calls on ABBV in the last 4 months.



There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 0 agree with Carter's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Carter


  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $190 on, Friday, March 22nd, 2024
  • Gary Nachman of "Raymond James" Maintained at Buy with Increased Target to $189 on, Tuesday, February 6th, 2024
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $195 on, Tuesday, February 6th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $200 on, Monday, February 5th, 2024
  • Tim Lugo of "William Blair" Upgraded from Hold to Buy on, Monday, January 29th, 2024
Contributing Sources